<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549<BR>
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B><FONT style="font-size:14pt">Current Report</FONT><BR>
Pursuant To Section&nbsp;13 or 15 (d)&nbsp;of the<BR>
Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported) &#151;March&nbsp;22, 2006</B><BR>
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>NUCRYST PHARMACEUTICALS CORP.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)
<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Alberta, Canada</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-51686</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Not Applicable</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of<BR>
incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>NUCRYST Pharmaceuticals Corp.<BR>
50 Audubon Road<BR>
Wakefield, MA 01880</B></DIV>

<DIV align="center" style="font-size: 10pt">(Address of principal executive offices)</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>(780)&nbsp;992-5326</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Not applicable</B><BR>
(Former name or former address, if changed since last report)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (<I>see </I>General
Instruction A.2. below):
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="5%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="5%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="5%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="5%" style="background: transparent">&nbsp;</TD>
    <TD width="4%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 12pt">&nbsp;</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">(Former name or former address, if changed since last report)</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>







<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">








<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Item&nbsp;8.01</I></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Other Events.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Please see Exhibits &#147;A&#148; and &#147;B&#148; attached.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B><I>Item&nbsp;9.01</I></B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Financial Statements and Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit &#147;A&#148; &#151; Code of Conduct and Ethics for Directors, Officers and Employees
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit &#147;B&#148; &#151; Finance Code of Conduct for Chief Executive and Senior Financial
Officers
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><FONT style="font-variant: SMALL-CAPS"><B>Nucryst Pharmaceuticals Corp.</B></FONT><BR> <BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left"><B>/s/<I>Carol L. Amelio</I></B>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left"><B>Carol L. Amelio</B>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left"><B>General Counsel and Corporate Secretary</B>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">DATE: March&nbsp;22, 2006

</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 12pt; margin-top: 12pt">EXHIBIT &#147;A&#148;
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 18pt"><B>NUCRYST Pharmaceuticals Corp.<BR>
Code of Conduct and Ethics for Directors, Officers and Employees</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Board of Directors (the &#147;Board&#148;) of NUCRYST Pharmaceuticals Corp. (the &#147;Corporation&#148;) has
developed and adopted this Code of Conduct and Ethics (the &#147;Code&#148;) applicable to its Directors,
Officers and Employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All Directors, Officers and Employees of the Corporation are accountable for adherence to this Code
and will at all times in relation to the Corporation:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Act honestly and ethically.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Comply with all applicable laws, rules and regulations of federal, provincial, state and local governments, and other
appropriate private and public regulatory agencies including, without limitation, all &#147;insider trading&#148; prohibitions.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Not use confidential information acquired as a result of their role with the Corporation for personal advantage.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Avoid all actual or apparent conflicts of interest between their personal and professional relationships, ethically
handling all such actual or apparent conflicts of interest.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Not (a)&nbsp;take for themselves any opportunity that properly belongs to the Corporation or is discovered through the use
of corporate property, information or position; or (b)&nbsp;use corporate property, information or position for personal
gain; nor (c)&nbsp;compete with any business activity of the Corporation.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Promptly and accurately provide all necessary information to assure that the Corporation&#146;s public reports, documents
and filings (including but not limited to those filed with any stock exchange or securities commission or in any other
public communication) are full, fair, accurate, timely and understandable and that the Corporation&#146;s public disclosure
requirements are fully met.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Promptly report any known violations of this Code to the Chief Financial Officer of the Corporation.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Not permit retaliation of any kind by or on behalf of the Corporation and its Directors, Officers and Employees against
good faith reports or complaints of violations of this Code or other illegal or unethical conduct.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Code may be amended, modified or waived from time to time by the Board in its sole discretion,
and waivers may also be granted by the Corporate Governance and Nominating Committee or the Audit
Committee of the Board, subject to the disclosure and other provisions of the applicable Canadian
and U.S. securities legislation and the applicable rules of the stock exchanges upon which the
Corporation&#146;s shares trade from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This Code does not summarize all laws, rules and regulations applicable to the Corporation and its
Directors, Officers and Employees. Whenever feasible, Directors, Officers and Employees should
consult the Chief Financial Officer of the Corporation, and the various guidelines that the
Corporation has prepared on specific laws, rules and regulations, in relation to any questions
regarding the applicability of this Code or any of its provisions.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 12pt; margin-top: 12pt">EXHIBIT &#147;B&#148;
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 18pt"><B>NUCRYST Pharmaceuticals Corp.<BR>
Finance Code of Conduct for<BR>
Chief Executive and Senior Financial Officers</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">NUCRYST Pharmaceuticals Corp.&#146;s Chief Executive Officer (CEO), Chief Financial Officer (CFO)
and other employees of the finance organization hold an important and elevated role in corporate
governance in that they are uniquely capable and empowered to ensure that all stakeholders&#146;
interests are appropriately balanced, protected and preserved. The Board of Directors of NUCRYST
Pharmaceuticals Corp. has developed and adopted this Finance Code of Conduct applicable to its CEO,
CFO and other senior finance employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">All employees covered by this Finance Code of Conduct are accountable for adherence to this Code of
Conduct and will:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Act responsibly and ethically, with honesty and integrity, avoiding actual or apparent conflicts of interest between
their personal and professional relationships, ethically handling all such actual or apparent conflicts of interest.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Provide stakeholders with information that is accurate, complete, objective, fair, relevant, timely and understandable,
including in company filings with securities regulators or commissions and in any other public communications made by
NUCRYST Pharmaceuticals Corp..</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Comply with applicable laws, rules and regulations of federal, provincial, state and local governments, and other
appropriate private and public regulatory agencies.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or
allowing one&#146;s independent judgment to be subordinated.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Respect the confidentiality of information acquired in the course of one&#146;s work except when authorized or otherwise
legally obligated to disclose.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Not use confidential information acquired in the course of one&#146;s work for personal advantage.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Be an example of ethical behavior as a responsible partner among peers, in the work environment and in the community.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Not unduly or fraudulently influence, coerce, manipulate, or mislead any authorized audit or interfere with any auditor
engaged in the performance of an internal or independent audit of the company&#146;s financial statements or accounting
books and records.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Promptly report any known violations of this Code of Conduct to the Audit Committee of the Board of Directors.</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "o30752e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 19973}]
{"company-data": {"conformed-name": "NUCRYST Pharmaceuticals Corp.", "cik": "0001344674", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "A0", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51686", "film-number": "06705143"}, "business-address": {"street1": "50 AUDUBON ROAD", "street2": "SUITE B", "city": "WAKEFIELD", "state": "MA", "zip": "01880", "phone": "781-224-1444"}, "mail-address": {"street1": "50 AUDUBON ROAD", "street2": "SUITE B", "city": "WAKEFIELD", "state": "MA", "zip": "01880"}}
e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant To Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) —March 22, 2006
NUCRYST PHARMACEUTICALS CORP.
(Exact name of registrant as specified in its charter)
Alberta, Canada
000-51686
Not Applicable
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
NUCRYST Pharmaceuticals Corp.
50 Audubon Road
Wakefield, MA 01880
(Address of principal executive offices)
Registrant's telephone number, including area code:
(780) 992-5326
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (
see
General
Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
(Former name or former address, if changed since last report)
Item 8.01
Other Events.
Please see Exhibits "A" and "B" attached.
Item 9.01
Financial Statements and Exhibits.
Exhibit "A" — Code of Conduct and Ethics for Directors, Officers and Employees
Exhibit "B" — Finance Code of Conduct for Chief Executive and Senior Financial
Officers
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Nucryst Pharmaceuticals Corp.
By:
/s/
Carol L. Amelio
Carol L. Amelio
General Counsel and Corporate Secretary
DATE: March 22, 2006
EXHIBIT "A"
NUCRYST Pharmaceuticals Corp.
Code of Conduct and Ethics for Directors, Officers and Employees
The Board of Directors (the "Board") of NUCRYST Pharmaceuticals Corp. (the "Corporation") has
developed and adopted this Code of Conduct and Ethics (the "Code") applicable to its Directors,
Officers and Employees.
All Directors, Officers and Employees of the Corporation are accountable for adherence to this Code
and will at all times in relation to the Corporation:
•
Act honestly and ethically.
•
Comply with all applicable laws, rules and regulations of federal, provincial, state and local governments, and other
appropriate private and public regulatory agencies including, without limitation, all "insider trading" prohibitions.
•
Not use confidential information acquired as a result of their role with the Corporation for personal advantage.
•
Avoid all actual or apparent conflicts of interest between their personal and professional relationships, ethically
handling all such actual or apparent conflicts of interest.
•
Not (a) take for themselves any opportunity that properly belongs to the Corporation or is discovered through the use
of corporate property, information or position; or (b) use corporate property, information or position for personal
gain; nor (c) compete with any business activity of the Corporation.
•
Promptly and accurately provide all necessary information to assure that the Corporation's public reports, documents
and filings (including but not limited to those filed with any stock exchange or securities commission or in any other
public communication) are full, fair, accurate, timely and understandable and that the Corporation's public disclosure
requirements are fully met.
•
Promptly report any known violations of this Code to the Chief Financial Officer of the Corporation.
•
Not permit retaliation of any kind by or on behalf of the Corporation and its Directors, Officers and Employees against
good faith reports or complaints of violations of this Code or other illegal or unethical conduct.
This Code may be amended, modified or waived from time to time by the Board in its sole discretion,
and waivers may also be granted by the Corporate Governance and Nominating Committee or the Audit
Committee of the Board, subject to the disclosure and other provisions of the applicable Canadian
and U.S. securities legislation and the applicable rules of the stock exchanges upon which the
Corporation's shares trade from time to time.
This Code does not summarize all laws, rules and regulations applicable to the Corporation and its
Directors, Officers and Employees. Whenever feasible, Directors, Officers and Employees should
consult the Chief Financial Officer of the Corporation, and the various guidelines that the
Corporation has prepared on specific laws, rules and regulations, in relation to any questions
regarding the applicability of this Code or any of its provisions.
EXHIBIT "B"
NUCRYST Pharmaceuticals Corp.
Finance Code of Conduct for
Chief Executive and Senior Financial Officers
NUCRYST Pharmaceuticals Corp.'s Chief Executive Officer (CEO), Chief Financial Officer (CFO)
and other employees of the finance organization hold an important and elevated role in corporate
governance in that they are uniquely capable and empowered to ensure that all stakeholders'
interests are appropriately balanced, protected and preserved. The Board of Directors of NUCRYST
Pharmaceuticals Corp. has developed and adopted this Finance Code of Conduct applicable to its CEO,
CFO and other senior finance employees.
All employees covered by this Finance Code of Conduct are accountable for adherence to this Code of
Conduct and will:
•
Act responsibly and ethically, with honesty and integrity, avoiding actual or apparent conflicts of interest between
their personal and professional relationships, ethically handling all such actual or apparent conflicts of interest.
•
Provide stakeholders with information that is accurate, complete, objective, fair, relevant, timely and understandable,
including in company filings with securities regulators or commissions and in any other public communications made by
NUCRYST Pharmaceuticals Corp..
•
Comply with applicable laws, rules and regulations of federal, provincial, state and local governments, and other
appropriate private and public regulatory agencies.
•
Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or
allowing one's independent judgment to be subordinated.
•
Respect the confidentiality of information acquired in the course of one's work except when authorized or otherwise
legally obligated to disclose.
•
Not use confidential information acquired in the course of one's work for personal advantage.
•
Be an example of ethical behavior as a responsible partner among peers, in the work environment and in the community.
•
Not unduly or fraudulently influence, coerce, manipulate, or mislead any authorized audit or interfere with any auditor
engaged in the performance of an internal or independent audit of the company's financial statements or accounting
books and records.
•
Promptly report any known violations of this Code of Conduct to the Audit Committee of the Board of Directors.